sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Enteral Collagen Peptide Protein Market by Form (Powder, Liquid); by Age Group (Adults (Above 18), Pediatrics (Below 18)); by End-User (Hospitals & Clinics, Homecare, Nursing Home); by Region (North America, Europe, Asia Pacific, Middle East & Africa (MEA), South America) : Global opportunity analysis and industry forecast 2021-2027

Enteral Collagen Peptide Protein Market by Form (Powder, Liquid); by...

Home / Categories / Food and Beverages
Enteral Collagen Peptide Protein Market by Form (Powder, Liquid); by Age Group (Adults (Above 18), Pediatrics (Below 18)); by End-User (Hospitals & Clinics, Homecare, Nursing Home); by Region (North America, Europe, Asia Pacific, Middle East & Africa (MEA), South America) : Global opportunity analysis and industry forecast 2021-2027
Enteral Collagen Peptide Protein Market...
Report Code
RO14/128/1770

Publish Date
01/Oct/2021

Pages
190
PRICE
$ 4570/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5450/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 7695/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

In 2020, the market of global enteral collagen peptide protein value was more than USD 13,586 thousand. The global enteral collagen peptide protein market is forecast to grow at a compound annual growth rate (CAGR) of more than 6% during the forecast period from 2021-2027.

Proteins derived from animal collagen are known as collagen peptide-proteins. Collagen peptide-protein helps provide patients with adequate nutrients whose gastrointestinal function is sufficient for digestion and absorption yet unable to do so orally. During this process, the patient may be unable to eat due to an illness, swallowing difficulties, or complications from surgery that affect their normal eating. This process involves injecting collagen peptides directly into the stomach, duodenum, or jejunum of patients.

Factors Affecting the Market

  • The rising prevalence of chronic illnesses, like osteoarthritis and heart disease, and the growing demand for collagen peptide protein in the healthcare sector are fueling the global market for enteral collagen peptide protein.
  • Government initiatives to promote a healthy diet are expected to enhance the opportunities for existing players and new entrants, given the aging population and favorable government initiatives to promote a healthy diet.
  • The growth of the enteral collagen peptide protein market in underdeveloped countries constrains by inadequate demand and lack of awareness.
  • The untapped potential of emerging economies anticipates providing new opportunities for the global market to expand.

COVID-19 Impact

The World Health Organization (WHO) considers the COVID-19 outbreak a public health emergency of international concern. The disease has spread to several countries around the world. The adverse effects of COVID-19 on the market for enteral collagen peptide proteins predict a decline in meat consumption, especially fish and bovine products. Consequently, this factor directly affects the production of collagen peptides since fish and beef wastes serve as an essential raw material to produce collagen products. In addition to its negative impact on partnerships and collaborations for enteral collagen peptide protein, the COVID-19 outbreak reduced the production of enteral collagen peptide protein products. As a result of the current global health crisis, the enteral collagen peptide protein market has been negatively affected.

Regional Overview

The enteral collagen peptide protein market in Asia-Pacific offers lucrative opportunities due to the rise in the elderly population, R&D investments in health care products designed to treat various chronic illnesses, and the demand for modern healthcare facilities. In the Asia-Pacific region, the rise in arthritis and leading manufacturers' focus on expanding into emerging markets to capture a large share of the market is forecast to boost the growth of the enteral collagen peptide protein market during the forecast period.

Key Companies

The leading prominent companies in the global enteral collagen peptide protein market are:

  • Abbott laboratories
  • Global Health Products, Inc.
  • Gelita AG
  • Danone SA (Nutricia)
  • Medtronic, Inc
  • Medline Industries, Inc
  • OP2 labs, LLC
  • Fresenius Kabi AG
  • Weishardt Holding SA
  • Dermarites Industries LLC
  • Other Prominent Players

Aim of the Report

The global market segmentation of the enteral collagen peptide protein consists of Form, Age Group, End-User, Region.

Segmentation based on Form

  • Powder
  • Liquid

Segmentation based on Age Group

  • Adults (Above 18)
  • Pediatrics (Below 18)

Segmentation based on End-User

  • Hospitals & Clinics
  • Homecare
  • Nursing Home

Segmentation based on Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Brazil
  • Argentina
  • Rest of South America

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com